• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-33b抑制肿瘤细胞生长,并与结直肠癌患者的预后相关。

MicroRNA-33b inhibits tumor cell growth and is associated with prognosis in colorectal cancer patients.

作者信息

Liao W, Gu C, Huang A, Yao J, Sun R

机构信息

Department of General Surgery, Jinshan Hospital, Fudan University, No. 1508, Longhang Road, Shanghai, 201508, People's Republic of China.

出版信息

Clin Transl Oncol. 2016 May;18(5):449-56. doi: 10.1007/s12094-015-1388-6. Epub 2015 Sep 2.

DOI:10.1007/s12094-015-1388-6
PMID:26329295
Abstract

PURPOSE

To explore the role of miR-33b in colorectal cancer (CRC) and the correlation between its expression and prognosis.

METHODS

The expressions of miR-33b between CRC tissues and normal tissues were measured by real-time PCR. The effects of miR-33b on cell proliferation and cell cycle progression were detected by MTT assay, colony formation assay and flow cytometry. The potential regulations of miR-33b on multiple genes expression were verified by Western blot. Furthermore, the association of miR-33b with CRC clinicopathologic features and prognosis was analyzed by Chi-squared test and Kaplan-Meier tests.

RESULTS

MiR-33b was downregulated in CRC compared with normal colorectal samples and miR-33b inhibited tumor cell growth and induced cell cycle arrest. Western blot assays and correlation analysis showed that miR-33b could regulate multiple growth-related genes. Moreover, the expression of miR-33b was associated with TNM stage and tumor size, and CRC patients with high miR-33b expression had a better prognosis.

CONCLUSION

Our data suggest that miR-33b functions as a tumor suppressor gene in CRC through regulating cell proliferation and cell cycle.

摘要

目的

探讨miR-33b在结直肠癌(CRC)中的作用及其表达与预后的相关性。

方法

采用实时荧光定量PCR检测CRC组织和正常组织中miR-33b的表达。通过MTT法、集落形成试验和流式细胞术检测miR-33b对细胞增殖和细胞周期进程的影响。通过蛋白质印迹法验证miR-33b对多个基因表达的潜在调控作用。此外,采用卡方检验和Kaplan-Meier检验分析miR-33b与CRC临床病理特征及预后的相关性。

结果

与正常结直肠样本相比,CRC中miR-33b表达下调,且miR-33b抑制肿瘤细胞生长并诱导细胞周期停滞。蛋白质印迹分析和相关性分析表明,miR-33b可调控多个与生长相关的基因。此外,miR-33b的表达与TNM分期和肿瘤大小相关,miR-33b高表达的CRC患者预后较好。

结论

我们的数据表明,miR-33b在CRC中作为肿瘤抑制基因发挥作用,通过调节细胞增殖和细胞周期来实现。

相似文献

1
MicroRNA-33b inhibits tumor cell growth and is associated with prognosis in colorectal cancer patients.微小RNA-33b抑制肿瘤细胞生长,并与结直肠癌患者的预后相关。
Clin Transl Oncol. 2016 May;18(5):449-56. doi: 10.1007/s12094-015-1388-6. Epub 2015 Sep 2.
2
MicroRNA-497 inhibits tumor growth and increases chemosensitivity to 5-fluorouracil treatment by targeting KSR1.微小RNA-497通过靶向KSR1抑制肿瘤生长并增强对5-氟尿嘧啶治疗的化学敏感性。
Oncotarget. 2016 Jan 19;7(3):2660-71. doi: 10.18632/oncotarget.6545.
3
CircTADA2A suppresses the progression of colorectal cancer via miR-374a-3p/KLF14 axis.环状 RNA TADA2A 通过 miR-374a-3p/KLF14 轴抑制结直肠癌细胞的进展。
J Exp Clin Cancer Res. 2020 Aug 15;39(1):160. doi: 10.1186/s13046-020-01642-7.
4
Up-regulation of NEK2 by microRNA-128 methylation is associated with poor prognosis in colorectal cancer.微小RNA-128甲基化导致的NEK2上调与结直肠癌的不良预后相关。
Ann Surg Oncol. 2014 Jan;21(1):205-12. doi: 10.1245/s10434-013-3264-3. Epub 2013 Sep 18.
5
miR-598 inhibits metastasis in colorectal cancer by suppressing JAG1/Notch2 pathway stimulating EMT.微小RNA-598通过抑制JAG1/Notch2信号通路刺激上皮-间质转化来抑制结直肠癌转移。
Exp Cell Res. 2017 Mar 1;352(1):104-112. doi: 10.1016/j.yexcr.2017.01.022. Epub 2017 Feb 1.
6
MicroRNA-29b is a Novel Prognostic Marker in Colorectal Cancer.微小RNA-29b是结直肠癌中的一种新型预后标志物。
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1410-8. doi: 10.1245/s10434-014-4255-8. Epub 2014 Dec 4.
7
C/EBP-β-activated microRNA-223 promotes tumour growth through targeting RASA1 in human colorectal cancer.C/EBP-β激活的微小RNA-223通过靶向RASA1促进人类结直肠癌的肿瘤生长。
Br J Cancer. 2015 Apr 28;112(9):1491-500. doi: 10.1038/bjc.2015.107. Epub 2015 Mar 31.
8
Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance.miR-1288 在结直肠癌中的调控:表达改变及其临床病理意义。
Mol Carcinog. 2014 Feb;53 Suppl 1:E36-44. doi: 10.1002/mc.21993. Epub 2013 Sep 5.
9
MiR-489 suppresses tumor growth and invasion by targeting HDAC7 in colorectal cancer.miR-489 通过靶向作用于结直肠癌中的 HDAC7 抑制肿瘤生长和侵袭。
Clin Transl Oncol. 2018 Jun;20(6):703-712. doi: 10.1007/s12094-017-1770-7. Epub 2017 Oct 25.
10
MicroRNA target for MACC1 and CYR61 to inhibit tumor growth in mice with colorectal cancer.MACC1和CYR61的微小RNA靶点可抑制结直肠癌小鼠的肿瘤生长。
Tumour Biol. 2016 Oct;37(10):13983-13993. doi: 10.1007/s13277-016-5252-2. Epub 2016 Aug 4.

引用本文的文献

1
Tissue micro-RNAs associated with colorectal cancer prognosis: a systematic review.与结直肠癌预后相关的组织微小RNA:一项系统评价
Mol Biol Rep. 2021 Feb;48(2):1853-1867. doi: 10.1007/s11033-020-06075-1. Epub 2021 Feb 17.
2
Construction and prognostic analysis of miRNA-mRNA regulatory network in liver metastasis from colorectal cancer.结直肠癌肝转移中miRNA-mRNA调控网络的构建及预后分析
World J Surg Oncol. 2021 Jan 4;19(1):7. doi: 10.1186/s12957-020-02107-z.
3
MicroRNA-33b Suppresses Epithelial-Mesenchymal Transition Repressing the MYC-EZH2 Pathway in HER2+ Breast Carcinoma.

本文引用的文献

1
MicroRNA-33a/b in lipid metabolism – novel “thrifty” models.脂质代谢中的微小RNA-33a/b——新型“节俭”模型。
Circ J. 2015;79(2):278-84. doi: 10.1253/circj.CJ-14-1252. Epub 2015 Jan 8.
2
HDL cholesterol and cancer risk among patients with type 2 diabetes.2型糖尿病患者的高密度脂蛋白胆固醇与癌症风险
Diabetes Care. 2014 Dec;37(12):3196-203. doi: 10.2337/dc14-0523. Epub 2014 Sep 11.
3
microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer.微小RNA-139-5p通过靶向Notch1在结直肠癌中发挥肿瘤抑制功能。
微小RNA-33b通过抑制HER2阳性乳腺癌中的MYC-EZH2通路来抑制上皮-间质转化
Front Oncol. 2020 Sep 10;10:1661. doi: 10.3389/fonc.2020.01661. eCollection 2020.
4
Tumor suppressor miR-33b-5p regulates cellular function and acts a prognostic biomarker in RCC.肿瘤抑制因子miR-33b-5p调节细胞功能,并作为肾细胞癌的预后生物标志物。
Am J Transl Res. 2020 Jul 15;12(7):3346-3360. eCollection 2020.
5
Downregulation of miR-33b promotes non-small cell lung cancer cell growth through reprogramming glucose metabolism miR-33b regulates non-small cell lung cancer cell growth.下调 miR-33b 通过重编程葡萄糖代谢促进非小细胞肺癌细胞生长 miR-33b 调节非小细胞肺癌细胞生长。
J Cell Biochem. 2019 Apr;120(4):6651-6660. doi: 10.1002/jcb.27961. Epub 2018 Oct 28.
6
Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.生物信息学分析鉴定胃癌中具有预后价值的枢纽基因。
World J Surg Oncol. 2018 Jun 19;16(1):114. doi: 10.1186/s12957-018-1409-3.
7
Prognostic value of microRNAs in colorectal cancer: a meta-analysis.微小RNA在结直肠癌中的预后价值:一项荟萃分析。
Cancer Manag Res. 2018 Apr 30;10:907-929. doi: 10.2147/CMAR.S157493. eCollection 2018.
Mol Cancer. 2014 May 26;13:124. doi: 10.1186/1476-4598-13-124.
4
MiR-133b acts as a tumor suppressor and negatively regulates TBPL1 in colorectal cancer cells.微小RNA-133b在结肠癌细胞中作为一种肿瘤抑制因子发挥作用,并对TBPL1进行负调控。
Asian Pac J Cancer Prev. 2014;15(8):3767-72. doi: 10.7314/apjcp.2014.15.8.3767.
5
Lipogenic gene expression profile in patients with gastric cancer.胃癌患者的脂肪生成基因表达谱
Mol Clin Oncol. 2013 Sep;1(5):825-827. doi: 10.3892/mco.2013.148. Epub 2013 Jul 17.
6
IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis.IL-6R/STAT3/miR-34a 反馈环促进 EMT 介导的结直肠癌侵袭和转移。
J Clin Invest. 2014 Apr;124(4):1853-67. doi: 10.1172/JCI73531. Epub 2014 Mar 18.
7
Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma.双重 CDK4/CDK6 抑制诱导神经母细胞瘤细胞周期停滞和衰老。
Clin Cancer Res. 2013 Nov 15;19(22):6173-82. doi: 10.1158/1078-0432.CCR-13-1675. Epub 2013 Sep 17.
8
Mir-33 regulates cell proliferation and cell cycle progression.miR-33 调控细胞增殖和细胞周期进程。
Cell Cycle. 2012 Mar 1;11(5):922-33. doi: 10.4161/cc.11.5.19421.
9
Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides.在非人类灵长类动物中抑制 miR-33a/b 可提高血浆高密度脂蛋白胆固醇并降低极低密度脂蛋白甘油三酯。
Nature. 2011 Oct 19;478(7369):404-7. doi: 10.1038/nature10486.
10
The proto-oncogene Pim-1 is a target of miR-33a.原癌基因 Pim-1 是 miR-33a 的靶标。
Oncogene. 2012 Feb 16;31(7):918-28. doi: 10.1038/onc.2011.278. Epub 2011 Jul 11.